Oslo Cancer Cluster Innovation Park´s grand opening on August 24th became a very special day: More than 290 invited guests and a huge media turnout celebrated the initiators Jónas Einarsson and Kaare Norum for turning the radical idea of an oncology innovation park integrating a high school into reality.
PCI Biotech has activated Oslo University Hospital as a new clinical site in the phase I/II study of Amphinex in patients with inoperable bile duct cancer.
BILAG DAGENS NÆRINGSLIV
Meltwater Newsfeed :
- PCI Biotech announces activation of Oslo University Hospital as a new clinical site August 31, 2015
- NLSDays 2015: Meet international life science leaders and discuss the sector’s future at the Nordic region's largest partnering meeting August 25, 2015
- Analyse i kampen mot kreft August 25, 2015
- Kreftforeningen: – En jubeldag for pasientene! August 25, 2015